Efficacy and safety of transcatheter valve-in-valve replacement for Mitroflow bioprosthetic valve dysfunction.

@article{Mosquera2018EfficacyAS,
  title={Efficacy and safety of transcatheter valve-in-valve replacement for Mitroflow bioprosthetic valve dysfunction.},
  author={Victor X Mosquera and Miguel Gonz{\'a}lez-Barbeito and Alberto Bouzas-Mosquera and Jos{\'e} Mar{\'i}a Herrera-Nore{\~n}a and Carlos Velasco and Jorge Salgado-Fern{\'a}ndez and Ram{\'o}n Calvi{\~n}o-Santos and Nicol{\'a}s V{\'a}zquez-Gonz{\'a}lez and Jos{\'e} Manuel V{\'a}zquez-Rodr{\'i}guez and Jos{\'e} Joaqu{\'i}n Cuenca-Castillo},
  journal={Journal of cardiac surgery},
  year={2018},
  volume={33 7},
  pages={
          356-362
        }
}
OBJECTIVES Bioprostheses with pericardial leaflets mounted externally on the stent pose a high risk for valve-in-valve (ViV) procedures. This study analyzed the efficacy and safety of ViV procedures for treating structural valve deterioration (SVD) in Mitroflow bioprostheses. METHODS Between January 2012 and August 2017, 11 patients (mean age 80.3 ± 5.6 years) were treated for SVD of Mitroflow bioprostheses with transcatheter ViV procedures (six transapical [TA] and five transfemoral [TF… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

Transfemoral valve-invalve Sapien 3 in a patient with an ascending aortic aneurysm

S Leung Wai Sang, JE Bavaria, JS Giri
  • J Card Surg
  • 2016

Balloon valuloplasty prior to transcatheter valve-in-valve implantation in a degenerated Mitroflow aortic bioprosthesis.

  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2013
VIEW 1 EXCERPT